1100 related articles for article (PubMed ID: 17440079)
1. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-activated kinase-2.
Wilkes MC; Mitchell H; Penheiter SG; Doré JJ; Suzuki K; Edens M; Sharma DK; Pagano RE; Leof EB
Cancer Res; 2005 Nov; 65(22):10431-40. PubMed ID: 16288034
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta regulates differentially the proliferation of fetal and adult human skin fibroblasts via the activation of PKA and the autocrine action of FGF-2.
Giannouli CC; Kletsas D
Cell Signal; 2006 Sep; 18(9):1417-29. PubMed ID: 16361081
[TBL] [Abstract][Full Text] [Related]
4. cAMP inhibits transforming growth factor-beta-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1/2 and Smad signaling in cardiac fibroblasts.
Liu X; Sun SQ; Hassid A; Ostrom RS
Mol Pharmacol; 2006 Dec; 70(6):1992-2003. PubMed ID: 16959941
[TBL] [Abstract][Full Text] [Related]
5. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis.
Halder SK; Anumanthan G; Maddula R; Mann J; Chytil A; Gonzalez AL; Washington MK; Moses HL; Beauchamp RD; Datta PK
Cancer Res; 2006 Jun; 66(12):6156-66. PubMed ID: 16778189
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
Schepers H; Wierenga AT; Eggen BJ; Vellenga E
Exp Hematol; 2005 Jul; 33(7):747-57. PubMed ID: 15963850
[TBL] [Abstract][Full Text] [Related]
8. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
9. Regulation of neuronal K(Ca) channels by beta-neuregulin-1 does not require activation of Ras-MEK-extracellular signal-regulated kinase signaling cascades.
Chae KS; Dryer SE
Neuroscience; 2005; 135(4):1013-6. PubMed ID: 16165293
[TBL] [Abstract][Full Text] [Related]
10. Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway.
Chen RH; Su YH; Chuang RL; Chang TY
Oncogene; 1998 Oct; 17(15):1959-68. PubMed ID: 9788439
[TBL] [Abstract][Full Text] [Related]
11. Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells.
Song CY; Kim BC; Lee HS
Transl Res; 2008 Jan; 151(1):27-35. PubMed ID: 18061125
[TBL] [Abstract][Full Text] [Related]
12. Cooperation of H2O2-mediated ERK activation with Smad pathway in TGF-beta1 induction of p21WAF1/Cip1.
Kim YK; Bae GU; Kang JK; Park JW; Lee EK; Lee HY; Choi WS; Lee HW; Han JW
Cell Signal; 2006 Feb; 18(2):236-43. PubMed ID: 15979845
[TBL] [Abstract][Full Text] [Related]
13. Cell type-dependent control of NF-Y activity by TGF-beta.
Alabert C; Rogers L; Kahn L; Niellez S; Fafet P; Cerulis S; Blanchard JM; Hipskind RA; Vignais ML
Oncogene; 2006 Jun; 25(24):3387-96. PubMed ID: 16434965
[TBL] [Abstract][Full Text] [Related]
14. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
[TBL] [Abstract][Full Text] [Related]
15. Doxycycline inhibits TGF-beta1-induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells.
Kim HS; Luo L; Pflugfelder SC; Li DQ
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):840-8. PubMed ID: 15728539
[TBL] [Abstract][Full Text] [Related]
16. Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-beta1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells.
Ding W; Shi W; Bellusci S; Groffen J; Heisterkamp N; Minoo P; Warburton D
J Cell Physiol; 2007 Sep; 212(3):796-806. PubMed ID: 17516543
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide regulates transforming growth factor-beta signaling in endothelial cells.
Saura M; Zaragoza C; Herranz B; Griera M; Diez-Marqués L; Rodriguez-Puyol D; Rodriguez-Puyol M
Circ Res; 2005 Nov; 97(11):1115-23. PubMed ID: 16239590
[TBL] [Abstract][Full Text] [Related]
18. beta-Adrenergic stimulation of rat cardiac fibroblasts promotes protein synthesis via the activation of phosphatidylinositol 3-kinase.
Colombo F; Noël J; Mayers P; Mercier I; Calderone A
J Mol Cell Cardiol; 2001 Jun; 33(6):1091-106. PubMed ID: 11444915
[TBL] [Abstract][Full Text] [Related]
19. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas.
Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P
Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity.
Kim HP; Lee MS; Yu J; Park JA; Jong HS; Kim TY; Lee JW; Bang YJ
Biochem J; 2004 Apr; 379(Pt 1):141-50. PubMed ID: 14720123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
